BlackRock’s NovaBay Pharmaceuticals NBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1
| Closed | -$4 | – | 5266 |
|
|
2023
Q4 | $4 | Hold |
1
| – | – | ﹤0.01% | 5292 |
|
|
2023
Q3 | $9 | Hold |
1
| – | – | ﹤0.01% | 5364 |
|
|
2023
Q2 | $15 | Hold |
1
| – | – | ﹤0.01% | 5395 |
|
|
2023
Q1 | $34 | Hold |
1
| – | – | ﹤0.01% | 5465 |
|
|
2022
Q4 | $41 | Hold |
1
| – | – | ﹤0.01% | 5656 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 5779 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 5818 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 5774 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 5750 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 5587 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 5455 |
|
|
2021
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 5186 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 5030 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 5011 |
|
|
2020
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 4878 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4949 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4962 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4976 |
|
|
2019
Q2 | $1K | Sell |
1
-11
| -92% | -$11K | ﹤0.01% | 4916 |
|
|
2019
Q1 | $18K | Sell |
12
-1
| -8% | -$1.5K | ﹤0.01% | 4563 |
|
|
2018
Q4 | $12K | Hold |
13
| – | – | ﹤0.01% | 4596 |
|
|
2018
Q3 | $30K | Buy |
13
+1
| +8% | +$2.31K | ﹤0.01% | 4537 |
|
|
2018
Q2 | $38K | Buy |
12
+2
| +20% | +$6.33K | ﹤0.01% | 4543 |
|
|
2018
Q1 | $41K | Hold |
10
| – | – | ﹤0.01% | 4412 |
|
|
2017
Q4 | $47K | Hold |
10
| – | – | ﹤0.01% | 4394 |
|
|
2017
Q3 | $54K | Hold |
10
| – | – | ﹤0.01% | 4397 |
|
|
2017
Q2 | $48K | Buy |
10
+9
| +900% | +$43.2K | ﹤0.01% | 4462 |
|
|
2017
Q1 | $3K | Buy |
+1
| New | +$3K | ﹤0.01% | 4778 |
|